Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: A multicenter study-part 2

Circulation

Volumn 128, Issue 16, 2013, Pages 1739-1747

  Sacher, Frédéric ^a   Probst, Vincent ^b   Maury, Philippe ^c   Babuty, Dominique ^d   Mansourati, Jacques ^e   Komatsu, Yuki ^f   Marquie, Christelle ^g   Rosa, Antonio ^h   Diallo, Abou ^a   Cassagneau, Romain ⁱ   Loizeau, Claire ^a   Martins, Raphael ^j   Field, Michael E ^a   Derval, Nicolas ^a   Miyazaki, Shinsuke ^e   Denis, Arnaud ^a   Nogami, Akihiko ^k   Ritter, Philippe ^a   Gourraud, Jean Baptiste ^b   Ploux, Sylvain ^a   Rollin, Anne ^c   Zemmoura, Adlane ^a   Lamaison, Dominique ^l   Bordachar, Pierre ^a   Pierre, Bertrand ^d   Jaïs, Pierre ^a   Pasquié, Jean Luc ^m   Hocini, Mélèze ^a   Legal, François ⁿ   Defaye, Pascal ⁱ   Boveda, Serge ^h   Iesaka, Yoshito ^f   Mabo, Philippe ^j   Haïssaguerre, Michel ^a   more..

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e BREST UNIVERSITY HOSPITAL   (France)

^f TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h CLINIQUE PASTEUR   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j RENNES UNIVERSITY HOSPITAL   (France)

^k YOKOHAMA ROSAI HOSPITAL   (Japan)

^l UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^m MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁿ POITIERS UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Brugada syndrome; death, sudden, cardiac; defibrillators, implantable

Indexed keywords

ADULT; ARTICLE; BRUGADA SYNDROME; DEVICE THERAPY; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK REDUCTION; SHOCK; SINUS TACHYCARDIA; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; T WAVE; TREATMENT INDICATION; TREATMENT OUTCOME;

BRUGADA SYNDROME; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE;

ADULT; AGED; BRUGADA SYNDROME; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84885850336     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.001941     Document Type: Article

References (22)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20:1391-1396.
2. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gérard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O'Neill MD, Garrigue S, Pierre B, Jaïs P, Pasquié JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haïssaguerre M, Mansourati J, Clémenty J, Le Marec H. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 2006;114:2317-2324. (Pubitemid 44847448)
3. Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T, Geelen P, Wellens F, Spreeuwenberg MD, Brugada P. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28:334-344.
4. Kharazi A, Emkanjoo Z, Alizadeh A, Nikoo MH, Jorat MV, Sadr-Ameli MA. Mid-term follow-up of patients with Brugada syndrome following a cardioverter defibrillator implantation: a single center experience. Indian Pacing Electrophysiol J. 2007;7:33-39. (Pubitemid 46117557)
5. Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I, Khalamizer V, Fuchs T, Boulos M, Geist M, Strasberg B, Ilan M, Belhassen B; Israeli Working Group on Cardiac Pacing and Electrophysiology. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J. 2008;10:435-439.
6. Steven D, Roberts-Thomson KC, Inada K, Seiler J, Koplan BA, Tedrow UB, Sweeney MO, Epstein LE, Stevenson WG. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators. J Cardiovasc Electrophysiol. 2011;22:1115-1119.
7. Daoulah A, Alsheikh-Ali AA, Ocheltree AH, Ocheltree S, Al-Kaabi S, Malik M, Al-Habib AK, Hamed A, Al-Rawahi N, Al-Sayegh A, Al-Hasaniah S, Ul-Haq E. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada Syndrome Registry. J Electrocardiol. 2012;45:327-332.
8. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the Second Consensus Conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659-670.
9. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, Babuty D, Sacher F, Giustetto C, Schulze-Bahr E, Borggrefe M, Haissaguerre M, Mabo P, Le Marec H, Wolpert C, Wilde AA. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. Circulation. 2010;121:635-643.
10. Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, Giordano U, Pappone C, Mascioli G, Rossetti G, De Nardis R, Colombo M. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol. 2012;59:37-45.
11. Delise P, Allocca G, Marras E, Giustetto C, Gaita F, Sciarra L, Calo L, Proclemer A, Marziali M, Rebellato L, Berton G, Coro L, Sitta N. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J. 2011;32:169-176.
12. Sacher F, Arsac F, Wilton SB, Derval N, Denis A, de Guillebon M, Ramoul K, Bordachar P, Ritter P, Hocini M, Clémenty J, Jaïs P, Haïssaguerre M. Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome. Heart Rhythm. 2012;9:1272-1279.
13. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275-2283.
14. Veltmann C, Kuschyk J, Schimpf R, Streitner F, Schoene N, Borggrefe M, Wolpert C. Prevention of inappropriate ICD shocks in patients with Brugada syndrome. Clin Res Cardiol. 2010;99:37-44.
15. Sacher F, Probst V, Bessouet M, Wright M, Maluski A, Abbey S, Bordachar P, Deplagne A, Ploux S, Lande G, Jaïs P, Hocini M, Haïssaguerre M, Le Marec H, Clémenty J. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population. Europace. 2009;11:489-494.
16. Hauser RG, Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm. 2004;1:399-405. (Pubitemid 39462611)
17. Messali A, Thomas O, Chauvin M, Coumel P, Leenhardt A. Death due to an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2004;15:953-956. (Pubitemid 39180261)
18. Veltmann C, Borggrefe M, Schimpf R, Wolpert C. Fatal inappropriate ICD shock. J Cardiovasc Electrophysiol. 2007;18:326-328.
19. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36-44.
20. Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol. 2012;60:1933-1939.
21. Belhassen B. Is quinidine the ideal drug for Brugada syndrome? Heart Rhythm. 2012;9:2001-2002.
22. Probst V, Plassard-Kerdoncuf D, Mansourati J, Mabo P, Sacher F, Fruchet C, Babuty D, Lande G, Guyomarc'h B, Le Marec H. The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients. Europace. 2011;13:1034-1039.